Oramed Pharmaceuticals Inc.
ORMP
$4.48
$0.102.28%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -23.13% | -47.70% | -6.53% | 37.52% | -25.03% |
| Total Receivables | 210.00% | -91.15% | 1,164.93% | -34.21% | 193.75% |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | -50.11% | -18.85% | 122.96% | 116.42% | -23.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | -21.63% | -48.86% | -2.09% | 37.46% | -24.68% |
|
|
|||||
| Total Current Assets | -21.63% | -48.86% | -2.09% | 37.46% | -24.68% |
| Net Property, Plant & Equipment | -7.71% | -6.81% | -6.64% | -6.29% | 50.74% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.21% | -5.08% | 132.04% | -75.97% | -18.12% |
| Total Assets | 37.49% | 16.45% | 4.70% | 36.37% | 9.59% |
|
|
|||||
| Total Accounts Payable | -22.25% | 8.58% | -20.89% | -21.68% | 40.47% |
| Total Accrued Expenses | -1.06% | -39.79% | 281.44% | -27.78% | 11.83% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -7.09% | -5.96% | 5.17% | 2.65% | 45.86% |
| Total Finance Division Other Current Liabilities | 3.96% | -47.93% | 240.88% | 182.85% | -58.29% |
| Total Other Current Liabilities | 3.96% | -47.93% | 240.88% | 182.85% | -58.29% |
| Total Current Liabilities | 1.59% | -44.66% | 211.91% | 65.69% | -32.76% |
|
|
|||||
| Total Current Liabilities | 1.59% | -44.66% | 211.91% | 65.69% | -32.76% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -1.83% | -8.70% | -8.32% | -9.10% | 440.00% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 109.86% | 69.78% | 0.34% | 204.65% | 84.95% |
| Total Liabilities | 70.65% | -1.76% | 71.34% | 124.21% | 5.96% |
|
|
|||||
| Common Stock & APIC | 0.32% | 0.07% | -0.82% | 0.11% | 0.13% |
| Retained Earnings | 91.82% | 31.04% | -0.70% | 28.31% | 7.21% |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 33.24% | 19.29% | -1.74% | 31.55% | 9.74% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 33.24% | 19.29% | -1.74% | 31.55% | 9.74% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -0.63% | -3.05% |
| Total Equity | 33.24% | 19.29% | -1.28% | 31.74% | 9.79% |
|
|
|||||